New study discovers inhibitors of protein linked to the devastating childhood brain cancer DIPG

Scientists at The Institute of Cancer Research, London in collaboration with a team at the Structural Genomics Consortium in Oxford (SGC) have created a new series of compound that could form the basis for drugs that target the devastating childhood brain cancer diffuse intrinsic pontine glioma, or DIPG.

Read more: https://www.icr.ac.uk/news-archive/new-study-discovers-inhibitors-of-protein-linked-to-the-devastating-childhood-brain-cancer-dipg